Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
Sunčica Kapor, Juan F. Santibáñez
Journal of Clinical Medicine (2021) Vol. 10, Iss. 13, pp. 2788-2788
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Macrophages in immunoregulation and therapeutics
Shanze Chen, Abdullah F. U. H. Saeed, Quan Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 792
Targeted modulation of myeloid-derived suppressor cells in the tumor microenvironment: Implications for cancer therapy
Yafeng Qi, Liying Zhang, Y Q Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117590-117590
Closed Access | Times Cited: 10
Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression
Manuel Mendes, Ana C. Monteiro, Estrela Neto, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4430-4430
Open Access | Times Cited: 7
Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
Di Chen, Lixia Xu, Mengjuan Xuan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 4
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine
Casey L. O’Connell, Maria R. Baer, Andreas Due Ørskov, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 24, pp. 5306-5316
Open Access | Times Cited: 18
Bone marrow immune cells and drug resistance in acute myeloid leukemia
Miao Zhang, You Yang, Jing Liu, et al.
Experimental Biology and Medicine (2025) Vol. 250
Open Access
Contemporary understanding of myeloid-derived suppressor cells in the acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) tumor microenvironment
Abdulrahman Alhajahjeh, Maximilian Stahl, Tae Kyoung Kim, et al.
Expert Review of Anticancer Therapy (2025), pp. 1-22
Closed Access
“Galectin-9: A double-edged sword in Acute Myeloid Leukemia”
Omolbanin Sargazi-Aval, Ali Mohammad Ahmadi, Ali Jihad Hemid Al-Athari, et al.
Annals of Hematology (2025)
Open Access
Blasts in context: the impact of the immune environment on acute myeloid leukemia prognosis and treatment
Yasmina Serroukh, Josée Hébert, Lambert Busque, et al.
Blood Reviews (2022) Vol. 57, pp. 100991-100991
Open Access | Times Cited: 15
Mesenchymal stem cell transplantation alleviated atherosclerosis in systemic lupus erythematosus through reducing MDSCs
Genhong Yao, Jingjing Qi, Xiaojing Li, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Bone Marrow Niches and Tumour Cells: Lights and Shadows of a Mutual Relationship
Valentina Granata, Laura Crisafulli, Claudia Nastasi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
The vicious cycle of chronic endometriosis and depression—an immunological and physiological perspective
Subuhi Sherwani, Mohd Wajid Ali Khan, R. Saravanan, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Immunosuppressive microenvironment in acute myeloid leukemia: overview, therapeutic targets and corresponding strategies
Chenyu Zha, Xinyu Yang, Jun Yang, et al.
Annals of Hematology (2024)
Closed Access | Times Cited: 2
New Perspectives on Myeloid-Derived Suppressor Cells and Their Emerging Role in Haematology
Nikoleta Bizymi, Andreas Μ. Matthaiou, Angelos Matheakakis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5326-5326
Open Access | Times Cited: 11
The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome
Likun Zheng, Lei Zhang, Yixuan Guo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Increase in Frequency of Myeloid-Derived Suppressor Cells in the Bone Marrow of Myeloproliferative Neoplasm: Potential Implications in Myelofibrosis
Sunčica Kapor, Sanja Momčilović, Slobodan Kapor, et al.
Advances in experimental medicine and biology (2023), pp. 273-290
Closed Access | Times Cited: 4
Myeloid-derived suppressor cells: a grey eminence in the AML tumor microenvironment?
Jan Philipp Bewersdorf, Amer M. Zeidan
Expert Review of Anticancer Therapy (2022) Vol. 22, Iss. 3, pp. 239-241
Open Access | Times Cited: 7
A novel function of collagen/PCL nanofiber interaction with MSCs in osteoarthritis is potentiation its immunomodulatory effect through increased ICAM expression
Gehan Abd-Elfatah Tawfeek, Heba A. Esaily
Transplant Immunology (2022) Vol. 73, pp. 101625-101625
Closed Access | Times Cited: 7
Recent advances in CAR-T therapy for the treatment of acute myeloid leukemia
Chenyu Zha, Jialu Song, Ming Wan, et al.
Therapeutic Advances in Hematology (2024) Vol. 15
Open Access | Times Cited: 1
From Immune Dysregulations to Therapeutic Perspectives in Myelodysplastic Syndromes: A Review
Thibault Comont, Emmanuel Treiner, François Vergez
Diagnostics (2021) Vol. 11, Iss. 11, pp. 1982-1982
Open Access | Times Cited: 8
In Vitro Insights Into the Influence of Marrow Mesodermal/Mesenchymal Progenitor Cells on Acute Myelogenous Leukemia and Myelodysplastic Syndromes
Jane L. Liesveld, Jaques Galipeau
Stem Cells (2023) Vol. 41, Iss. 9, pp. 823-836
Closed Access | Times Cited: 2
Diagnosis of Myelodysplastic Syndromes: From Immunological Observations to Clinical Applications
Yannick Simoni, Nicolas Chapuis
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1659-1659
Open Access | Times Cited: 3
Mesenchymal Stem Cells and Myeloid-Derived Suppressor Cells Interplay in Adjuvant-Induced Arthritis Rat Model
Faten A. M. Abo-Aziza, Basma M. Wasfy, Sanaa M.R. Wahba, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110300-110300
Closed Access | Times Cited: 1
Cholesterol Metabolism-Mediated Immune Regulation and Cancer Immunotherapy
Jiayu Zhang, Xinting Zhu, Leng Han, et al.
(2024)
Closed Access
Single-cell transcriptomics unveil a unique molecular profile of mesenchymal stem/stromal cell-induced myeloid-derived immune suppressor cells
Mohamed Hammad, Hossam M. Ashour
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1612-1613
Closed Access
Page 1 - Next Page

Scroll to top